Lansoprazole Zydus France

Lansoprazole, the active ingredient in Lansoprazole Zydus France, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is indicated for conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and ulcer prevention in at‑risk patients.

GNH USA supplies Lansoprazole Zydus France as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric proton pump to lower acid secretion, making it useful for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and reduces recurrence. - NSAID‑induced ulcer prophylaxis: lowers risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics.

Adverse reactions may occur with lansoprazole use.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Diarrhea: loose stools that usually resolve without intervention. - Abdominal pain: discomfort or cramping in the stomach region. - Nausea: feeling of unease or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): may include rash, swelling, and breathing difficulty. - Clostridioides difficile infection: presents with severe watery diarrhea. - Low magnesium (hypomagnesemia): can cause muscle cramps, seizures, or cardiac arrhythmias.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in patients with severe impairment. - Monitor magnesium levels: prolonged treatment may lead to hypomagnesemia. - Avoid concomitant use with strong CYP2C19 inhibitors unless clinically justified. - Use with caution in liver disease: monitor hepatic enzymes periodically. - Pregnancy and lactation: discuss potential risks with the prescriber. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lansoprazole may interact with several medicines; categorize the risk level.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, potentially increasing cardiovascular risk. - Atazanavir: decreased absorption of atazanavir, compromising antiviral efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer coagulation monitoring. - Digoxin: may raise serum digoxin concentrations, necessitating dose adjustment. - Methotrexate: increased toxicity risk, especially at high doses.